|
Who is
Majid Ali, M.D.
►
Dr. Ali's CV
Majid Ali is a
pioneer who is changing the face of medicine with his
innovative and spirited approach.
His credentials are
impeccable
Complementary Medicine Journal
"I stand in awe of Ali's
superb scientific knowledge, his insights into the nature of
the the healing process and his ability to explain hard
science."
Aubrey Worrell, MD
Past President, the American Academy of
Environmental Medicine
Majid Ali,
M.D.
Editor,
The Journal of Integrative Medicine
Formerly, Associate Professor of Pathology (adj.), College
of Physicians and Surgeons of Columbia University, NY
Formerly, President of Staff and
Chief Pathologist, Holy Name Hospital, Teaneck, NJ
Fellow, Royal College of Surgeons of England
- Diplomate,
American Board of Anatomic and Clinical Pathology
Diplomate, American Boards of Environmental Medicine
Past President Capital University of Integrative
Medicine
Aging Healthfully Supplements
Now You Can Order Online
Oral Chelation
Aging
Healthfully
proudly offers the
Oral EDTA Chelation Protocol
developed and used
by
Majid Ali, M.D.
in his practice for
over twenty
years.
|
Is Chemotherapy
a Good Option?
Majid Ali, M.D.
Should chemotherapy be given to a 15-year-old girl with
acute leukemia? Categorically yes! At my present state of
knowledge and experience, I am not aware of any cases in
which acute leukemia was controlled by nutritional, herbal,
or energy therapies for extended periods of time. By
contrast, chemotherapy in experienced hands can control
acute leukemia in a majority of cases.
Should chemotherapy be given to a 65-year-old man with a
low-grade prostate cancer? In most cases, my answer will be:
No. At my present state of knowledge and experience, most
cancers of the prostate gland, within that age group, can be
controlled with the Oxygen Protocol for several years (up to
19 years among my own patients). In advanced cases of
prostate cancer, I have seen some good initial results with
chemotherapy drugs (selected on the basis of the results of
chemosensitivity tests) administered concurrently with
strong nutrient, herbal, and detox therapies. However, the
follow-up to date in such instances has been too limited to
allow me to take a firm position on that subject. Time will
define the real long-term efficacy of such chemotherapy
regimens. I might point out here that chemotherapy regimens
based on broad chemosensitivity test profiles are generally
available in Europe but not in the U.S. at this time.
The crucial point here is this:
Each individual with cancer requires an individualized
assessment and treatment plan. There is no room here for
dangerous generalizations.
I want to emphasize that there is a crucial difference
between individualized chemotherapy, which is in use in some
German clinics and some other countries, and the protocol
chemotherapy being administered in the U.S. at present. In
my view, the German oncologists are ahead of their U.S.
counterparts, both in technologic advancement and openness
of mind. The difference between the two forms of
chemotherapy is critical. Regrettably, the U.S. protocol
chemotherapy, with some exceptions, make no attempts to
determine the sensitivity of cancer cells to a broad range
of genetic, enzymatic, or receptor elements. The choice of
the drug (s) to be used is limited to a few "approved"
agents C two drugs for leukemia, three for lung cancer, etc.
C and oncologists are effectively barred from trying the
so-called "un-approved" regimens.
In individualized chemotherapy, the focus is on the
sensitivity profile of a specific cancer as determined by
objective laboratory tests. The crucial importance of this
distinction can be driven home with the analogy of culture
and sensitivity testing for bacterial infections. Imagine if
the American Society of Clinical Pathologists were to ban
the use of culture and sensitivity testing for infectious
disorders and demand that doctors treat infections only with
pre-assigned "protocol" antibiotics. One can only hope that
the rich, close-minded, and stubborn big boys at the
American Cancer Society can be persuaded to consider broader
cancer chemosensitivity profiling before millions more
persons with cancer suffer needless toxicity of blinded
chemotherapy and lose their lives.
On some occasions, I have heard "holistic" doctors
vehemently denounce chemotherapy. They do not do so because
they have effective therapies on hand to control cancer. How
can any therapy be denounced until one has a treatment
option that is at least as good as that being denounced?
Regrettably, whenever I encountered blanket denouncement of
chemotherapy from holistic doctors, it was not accompanied
by any data to show that there was something else that was
safer and more effective than chemotherapy for the cancer in
question.
Many oncologists regularly administer chemotherapy when they
know that the drugs being used are highly toxic and are not
known to control the type of cancer in question. Sadly, on
too many occasions, I have heard them say,
"I had to do something."
With the above line, oncologists defend their decision to
administer chemotherapy. No one has to be given toxic drugs
simply because the oncologists will not make the effort to
learn how to use supportive nontoxic therapies. It is true
that in many advanced cases the therapies of the Oxygen
Protocol described in this book may not significantly
prolong life. However, from many years of experience, I know
that supportive oxystatic therapies add to the quality of
life and are never toxic to the patient. At the very least,
such therapies do not make a sick person sicker, as chemo
drugs often do.
"I know chemotherapy does not work for that cancer, but I
did it for anecdotal reasons."
This is the second sentence that I have commonly heard from
oncologists. This statement is equally preposterous. It is
interesting how oncologists regularly ridicule holistic
practitioners for being anecdotal, and yet accept the logic
of anecdotal experience to justify administering poisonous
chemo drugs for types of cancers that do not respond
positively to these drugs.
I have also seen some oncologists employ scare techniques to
intimidate patients and force them to undergo chemotherapy
for types of cancer that do not respond to such treatment.
That is deplorable. It is hard to see how any physician can
be justified in forcing a hesitant patient to receive a
highly toxic treatment that has no proven efficacy.
The most disturbing aspect of the prevailing practice of
oncology is this: Ineffective and effective chemotherapy
drugs are administered with equal frequency. Specifically,
chemotherapy is administered for cancers that initially
respond to chemo drugs as commonly as for those cancers that
do not respond to chemotherapy, even in a limited way. How
common is that unconscionable practice? It is far more than
any person outside of medicine can guess. I refer the reader
to Dr. Jerome P. Kassirer's book, On the Take, for a
chilling account of the frequency with which persons with
cancer are given highly toxic and ineffective drugs only for
meeting the profitability goals of oncology hospitals and
oncologists. Of note, Dr. Kassirer was the editor-in-chief
of The New England Journal of Medicine for over eight years.
The issue of a person with cancer rejecting chemotherapy is
a different and an important concern. Many people have
witnessed cases of horrible toxicity of chemotherapy C
including deaths from such complications as kidney or liver
failure C in regard to their family or friends. They have an
understandable distrust of chemotherapy.
|
| |
|
NOW
AVAILABLE FOR DOWNLOAD
The classic work
on the subject
E-Book 560 pages
$9.95
Now Available as
Instant Download
Integrative Protocols -
Vol 12 Principles and
Practices
of Integrative Medicine
Includes
Dr. Ali's
IV and IM formulations
E-Book price $35
Book price $95
Integrative Protocols -
Vol 11 Principles and
Practices
of Integrative Medicine
E-Book price $35
Book price $95
Dr.
Ali discusses Dysoxygenosis and varying
chronic diseases.
Chapter 1 Under Darwin’s Glow
Chapter 2 Energy Deficit States
Chapter 3 Integration
Chapter 4 The Oxygen Order of Life
Chapter 5 Oxygen
Chapter 6 Aging
Chapter 7 Inflammation
Chapter 8 Pain
Chapter 9 Heart Disease
Chapter 10 Asthma
Chapter 11 Renal Insufficiency
Chapter 12 Osteoporosis
Chapter 13 Metalicised Mouths
Chapter 14 Hormone Disorders
Chapter 15 Arrested Growth |
|
| |
| |
|
Spend 60 Hours with
Majid Ali MD
Dr. Ali's DVD Video library featuring 38 DVDs
Only $300
Free shipping too!
ORDER NOW |
DVDs
only $15 each!
|
An
extensive series of information on DVD
for the following:
|
|
